Middle East and Africa Plasma Fractionation Market to Grow at a CAGR of 5.2% to reach US$ 3,490.73 million from 2021 to 2028

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Middle East and Africa Plasma Fractionation Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Middle East and Africa Plasma Fractionation Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising need for plasma-based treatments
5.1.2 Growing awareness of blood disorders

5.2 Market Opportunities

5.2.1 Expansion in the global healthcare market
5.2.2 Growth in blood plasma-based therapies

5.3 Future Trends

5.3.1 Advances in protein fractionation
5.3.2 Increase in the number of plasma-derived therapies

5.4 Impact of Drivers and Restraints

6. Middle East and Africa Plasma Fractionation Market Regional Analysis

6.1 Middle East and Africa Plasma Fractionation Market Overview

6.2 Middle East and Africa Plasma Fractionation Market Revenue 2019-2028 (US$ Million)

6.3 Middle East and Africa Plasma Fractionation Market Forecast Analysis

7. Middle East and Africa Plasma Fractionation Market Analysis – by Product

7.1 Immunoglobulin

7.1.1 Overview
7.1.2 Immunoglobulin: Middle East and Africa Plasma Fractionation Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Albumin

7.2.1 Overview
7.2.2 Albumin: Middle East and Africa Plasma Fractionation Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Coagulation Factor Concentrates

7.3.1 Overview
7.3.2 Coagulation Factor Concentrates: Middle East and Africa Plasma Fractionation Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Protease Inhibitors

7.4.1 Overview
7.4.2 Protease Inhibitors: Middle East and Africa Plasma Fractionation Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Other Plasma Products

7.5.1 Overview
7.5.2 Other Plasma Products: Middle East and Africa Plasma Fractionation Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East and Africa Plasma Fractionation Market Analysis – by Application

8.1 Neurology

8.1.1 Overview
8.1.2 Neurology: Middle East and Africa Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Immunology

8.2.1 Overview
8.2.2 Immunology: Middle East and Africa Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Hematology

8.3.1 Overview
8.3.2 Hematology: Middle East and Africa Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Critical Care

8.4.1 Overview
8.4.2 Critical Care: Middle East and Africa Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Pulmonology

8.5.1 Overview
8.5.2 Pulmonology: Middle East and Africa Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Other Applications

8.6.1 Overview
8.6.2 Other Applications: Middle East and Africa Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)

9. Middle East and Africa Plasma Fractionation Market Analysis – by End User

9.1 Hospitals and Clinics

9.1.1 Overview
9.1.2 Other Applications: Middle East and Africa Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Clinical Research Laboratories

9.2.1 Overview
9.2.2 Other Applications: Middle East and Africa Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Academic Institutes

9.3.1 Overview
9.3.2 Other Applications: Middle East and Africa Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)

10. Middle East and Africa Plasma Fractionation Market – Middle East and Africa Analysis

10.1 Middle East and Africa

10.1.1 Middle East and Africa Plasma Fractionation Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 Middle East and Africa Plasma Fractionation Market – Revenue and Forecast Analysis – by Country
10.1.1.1 South Africa: Middle East and Africa Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 South Africa: Middle East and Africa Plasma Fractionation Market Breakdown, by Product
10.1.1.1.2 South Africa: Middle East and Africa Plasma Fractionation Market Breakdown, by Application
10.1.1.1.3 South Africa: Middle East and Africa Plasma Fractionation Market Breakdown, by End User

10.1.1.2 Saudi Arabia: Middle East and Africa Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Saudi Arabia: Middle East and Africa Plasma Fractionation Market Breakdown, by Product
10.1.1.2.2 Saudi Arabia: Middle East and Africa Plasma Fractionation Market Breakdown, by Application
10.1.1.2.3 Saudi Arabia: Middle East and Africa Plasma Fractionation Market Breakdown, by End User

10.1.1.3 UAE: Middle East and Africa Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 UAE: Middle East and Africa Plasma Fractionation Market Breakdown, by Product
10.1.1.3.2 UAE: Middle East and Africa Plasma Fractionation Market Breakdown, by Application
10.1.1.3.3 UAE: Middle East and Africa Plasma Fractionation Market Breakdown, by End User

10.1.1.4 Rest of Middle East and Africa: Middle East and Africa Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Rest of Middle East and Africa: Middle East and Africa Plasma Fractionation Market Breakdown, by Product
10.1.1.4.2 Rest of Middle East and Africa: Middle East and Africa Plasma Fractionation Market Breakdown, by Application
10.1.1.4.3 Rest of Middle East and Africa: Middle East and Africa Plasma Fractionation Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Middle East and Africa Plasma Fractionation Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Bharat Serums and Vaccines Limited (BSV)

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Bio Products Laboratory Ltd.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Biotest AG.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 CSL Limited

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Grifols, S.A.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Kedrion S.p.A

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Octapharma AG

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 SK Plasma

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights